Radiation Therapy

Survivors of childhood cancer are at risk for neurocognitive decline later in life related to the disease and treatment, a complication that may become more common as cancer treatments improve and more survivors reach adulthood.

National Prostate Cancer Awareness Month is observed every September.

Treatment at high-volume radiation therapy facilities correlated with improved survival among select patients with common malignancies, according to study results published in Cancer.

Proton therapy (PT) is a potentially important radiation modality for primary brain tumors due to its unique dose distributions. Unlike photon radiation, PT dose is characterized by a well-defined maximal range where the majority of the dose is deposited, followed by a rapid dose falloff to zero distally within a mere few millimeters.

More than 3 decades after receiving FDA approval, proton beam radiation therapy has failed to find a footing as a go-to treatment for many cancers in the United States.

American Society for Radiation Oncology issued its first clinical guideline for sarcoma.

Members of American Society for Radiation Oncology elected three new officers to ASTRO’s board of directors.

In the 2016 animated film “Moana,” the title character bravely battled a volcanic demon and saved her people.

Adjuvant radiation therapy immediately after surgery improved survival among men with prostate cancer and high-risk features, according to study results published in Journal of Clinical Oncology.

Frederick L. Locke, MD, has been awarded a clinical research grant by The Leukemia & Lymphoma Society in collaboration with Moffitt Cancer Center.